Chemoinformaics analysis of 8-P-HYDROXYBENZYLISOVITEXIN
| Molecular Weight | 538.505 | nRot | 5 |
| Heavy Atom Molecular Weight | 512.297 | nRig | 30 |
| Exact Molecular Weight | 538.148 | nRing | 5 |
| Solubility: LogS | -3.369 | nHRing | 2 |
| Solubility: LogP | 2.2 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 3 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 22 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 23 |
| nHA | 11 | APOL | 72.9186 |
| nHD | 8 | BPOL | 30.4234 |
| QED | 0.182 |
| Synth | 4.153 |
| Natural Product Likeliness | 1.597 |
| NR-PPAR-gamma | 0.96 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.142 |
| HIA | 0.91 |
| CACO-2 | -6.189 |
| MDCK | 0.00000437 |
| BBB | 0.01 |
| PPB | 0.978617 |
| VDSS | 0.588 |
| FU | 0.031618 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.027 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.118 |
| CYP2c9-sub | 0.769 |
| CYP2d6-inh | 0.063 |
| CYP2d6-sub | 0.203 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.062 |
| CL | 3.092 |
| T12 | 0.629 |
| hERG | 0.027 |
| Ames | 0.773 |
| ROA | 0.423 |
| SkinSen | 0.273 |
| Carcinogencity | 0.071 |
| EI | 0.011 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.963 |
| Antiviral | Yes |
| Prediction | 0.691113 |